Functional brain scans—now available on-site with our ultra-compact, state-of-the-art Positrigo NeuroLF PET scanner.
What is PET Brain Imaging?
Positron Emission Tomography (PET) maps metabolic activity in the brain by tracing a minute dose of radiolabeled glucose or amyloid-binding agent. Areas that consume more—or less—energy light up on the scan, giving neurologists precise insight into disorders such as Alzheimer’s disease, epilepsy, brain tumors, and movement disorders. By visualising function rather than structure, PET can reveal disease years before changes appear on CT or MRI.
Our Technology: Positrigo NeuroLF
We have invested in the NeuroLF system—an award-winning, FDA-cleared dedicated brain PET scanner. The device is:
- Ultra-compact: fits in a 10 × 10 ft room, with minimal shielding or construction requirements.
- Patient-centric: seated scanning position and quick acquisition times improve comfort and reduce motion artifacts.
- Workflow-friendly: intuitive interface integrates seamlessly with existing imaging and PACS systems.
- Cost-efficient: lower operating costs make advanced neuro-imaging accessible in an outpatient setting.
The system received FDA 510(k) clearance in July 2024, underscoring its safety and clinical effectiveness.
Who Benefits from NeuroLF PET Scanning?
- Early evaluation of cognitive decline / Alzheimer’s & other dementias
- Pre-surgical mapping for epilepsy and seizure disorders
- Characterisation and follow-up of primary or metastatic brain tumours
- Differential diagnosis of movement disorders such as Parkinson’s disease
- Monitoring response to emerging disease-modifying therapies